Clinical Trial: A Study of LY3819469 in Participants With Impaired and Normal Renal Function
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: Renal Insufficiency
Study Type: INTERVENTIONAL
Official Title: Pharmacokinetics of LY3819469 Following Subcutaneous Dose in Participants With Renal Impairment Compared With Participants With Normal Renal Function
Brief Summary:
The main purpose of this study is to assess the amount of study drug (LY3819469) that reaches the bloodstream and the time it takes for the body to get rid of it when given to participants with renal (kidney) impairment compared to participants with normal renal function.The safety and tolerability of LY3819469 will also be evaluated in these participants.The study will last up to 17 weeks including screening period.
Read more